warning icon

COVID-19 DEW Report, powered by Reformulary®Read more


Health Canada to start real-time review of Medicago COVID-19 vaccine

Health Canada will begin a rolling review of efficacy and safety data from Quebec-based Medicago’s late-stage COVID-19 vaccine trial. Rolling reviews allow data to accepted on an on-going basis while a trial is still underway. The company is making its plant-based vaccine in partnership with GlaxoSmithKline, who are producing a booster for it. Data from a mid-stage trial will be reported in full by the end of April. Medicago’s vaccine is widely seen as the most advanced Canadian candidate.

Published: April 23, 2021

CBC News

Read Article